Intravitreal Injection of Triamcinolone
Open Access
- 1 July 2004
- journal article
- review article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (7), 1794-1797
- https://doi.org/10.2337/diacare.27.7.1794
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- MACULAR BUCKLING FOR RETINAL DETACHMENT DUE TO MACULAR HOLE IN HIGHLY MYOPIC EYES WITH POSTERIOR STAPHYLOMARetina, 2000
- INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2000
- Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive TherapyNew England Journal of Medicine, 2000
- Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1Published by Elsevier BV ,1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The 14-year incidence of visual loss in a diabetic population,Ophthalmology, 1998
- Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids.American Journal of Respiratory Cell and Molecular Biology, 1997
- Exudative macular degeneration and intravitreal triamcinolone A pilot studyAustralian and New Zealand Journal of Ophthalmology, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983